YHR054C Antibody

What is YHR054C and why are antibodies against it important in yeast research?

YHR054C is a gene locus in Saccharomyces cerevisiae, commonly known as baker's yeast. The gene is located on chromosome VIII, and antibodies targeting the protein product are essential for investigating its expression, localization, and function within the cell. Antibodies against YHR054C enable researchers to track this protein in various experimental contexts, providing insights into fundamental biological processes in this model organism. The S. cerevisiae reference genome, derived from laboratory strain S288C, serves as the foundation for identifying and characterizing this gene and its protein product . YHR054C antibodies allow researchers to study protein-protein interactions, cellular pathways, and functional genomics in this widely used model eukaryote.

How should I select an appropriate YHR054C antibody for my research?

Selecting an appropriate YHR054C antibody requires careful consideration of several factors. First, identify your experimental application (Western blotting, immunoprecipitation, ChIP, etc.) and ensure the antibody has been validated for that specific use. Look for antibodies with demonstrated specificity, such as those tested in knockout models or through comparative analyses. For YHR054C, which is specific to Saccharomyces cerevisiae strain ATCC 204508/S288c (UniProt: P38780), ensure the antibody has been specifically raised against and tested with this strain .

Consider antibodies that have undergone rigorous validation processes, including testing across multiple applications and confirmation with orthogonal methods. For instance, antibodies validated through standardized characterization platforms like the one developed by the Structural Genomics Consortium researchers show higher reliability . Always review available validation data, including specificity tests, cross-reactivity assessments, and performance in your specific application before making a selection.

What experimental controls should I include when using YHR054C antibody in Western blotting?

When using YHR054C antibody for Western blotting, several essential controls should be included to ensure reliable and interpretable results:

• Positive control: Include lysates from wild-type S. cerevisiae strain S288c known to express YHR054C.

• Negative control: Use lysates from YHR054C knockout strains when available, or from strains where the protein is known to be absent.

• Loading control: Include antibodies against housekeeping proteins like actin or GAPDH to normalize for total protein loading.

• Molecular weight markers: Include standard protein markers to confirm the detected band is at the expected molecular weight.

• Primary antibody control: Omit the primary antibody but include the secondary antibody to identify any non-specific binding of the secondary antibody.

Follow standard Western blot protocols, including proper sample preparation (20-50 μg protein per lane), sonication (10 minutes using 30-second on/off cycles at 70% intensity), transfer to nitrocellulose, blocking with 5% BSA, and overnight incubation with the primary antibody at 4°C . These controls help distinguish specific signal from background and validate the specificity of the observed bands.

How can I validate the specificity of YHR054C antibody across different experimental contexts?

Validating the specificity of YHR054C antibody requires a multi-faceted approach across different experimental contexts:

• Genetic validation: Test the antibody in YHR054C knockout strains, which should show no signal. This provides the most definitive evidence of specificity.

• Epitope mapping: Determine which region of YHR054C the antibody recognizes, and assess conservation of this region across related proteins to predict potential cross-reactivity.

• Cross-application validation: Test the antibody in multiple applications (Western blot, immunoprecipitation, immunofluorescence) to ensure consistent specificity across techniques.

• Orthogonal detection methods: Compare antibody results with orthogonal methods of detecting the protein, such as mass spectrometry or RNA expression data.

• Multiple antibody comparison: Test multiple antibodies that target different epitopes of YHR054C and compare their detection patterns .

For comprehensive validation, follow standardized characterization protocols like those developed by YCharOS (Antibody Characterization through Open Science), which provides side-by-side testing of commercially available antibodies across key applications, including comparison with knockout cell lines . This rigorous approach helps establish confidence in antibody specificity across diverse experimental systems.

What are the optimal conditions for using YHR054C antibody in chromatin immunoprecipitation (ChIP) experiments?

For optimal ChIP experiments using YHR054C antibody, follow these detailed methodological guidelines:

• Crosslinking: Fix yeast cells with 1% formaldehyde for 10 minutes at 37°C, followed by quenching with glycine (0.125M) for 5 minutes at room temperature.

• Cell lysis and chromatin preparation: Lyse cells in cellular lysis buffer (5mM PIPES pH 8, 85 mM KCl, 0.5% NP40), then nuclear lysis buffer (50 mM Tris pH 8, 10 mM EDTA pH 8, 1% SDS). Sonicate for 45 minutes using 30-second on/off cycle repeats at 70% intensity to shear chromatin to fragments of 200-500 bp .

• Immunoprecipitation: Use 10 μg of crosslinked DNA per immunoprecipitation. Pre-clear the chromatin with Protein A beads before adding YHR054C antibody. Include a control spike-in chromatin (e.g., 2 μg Drosophila chromatin) for normalization.

• Antibody incubation: Incubate chromatin with YHR054C antibody overnight at 4°C using Protein A Dynabeads. Include appropriate negative controls (IgG) and positive controls (e.g., histone H3 antibody) .

• Washing and elution: Perform stringent washing steps with multiple buffers of increasing stringency: IP buffer, TSE buffer, LiCl buffer, and TE buffer. Elute DNA from beads using proteinase K digestion and purify with a PCR cleanup kit.

• Validation: Verify enrichment of known target regions using qPCR before proceeding to sequencing or further analyses.

For ChIP-seq applications, ensure the YHR054C antibody is specifically validated for ChIP-seq, as antibodies that perform well in ChIP-qPCR do not necessarily perform well in genome-wide applications .

How can I troubleshoot non-specific binding or inconsistent results with YHR054C antibody?

When encountering non-specific binding or inconsistent results with YHR054C antibody, implement the following systematic troubleshooting approach:

• Antibody validation: Confirm the antibody's specificity using knockout controls or competitive binding assays. If possible, test multiple antibodies against different epitopes of YHR054C to identify the most specific option .

• Blocking optimization: Test different blocking agents (BSA, milk, serum) and concentrations. For YHR054C antibody applications, 5% BSA in PBST is often recommended for primary antibody incubation, while 5% milk in PBST works well for secondary antibody incubation .

• Antibody concentration: Titrate the antibody to determine the optimal concentration that maximizes signal-to-noise ratio. Begin with the manufacturer's recommended dilution and adjust as needed.

• Incubation conditions: Optimize incubation time and temperature. For Western blotting, overnight incubation at 4°C often improves specificity compared to shorter incubations at room temperature .

• Washing stringency: Increase the number and duration of washing steps, or adjust salt concentration in washing buffers to reduce non-specific binding.

• Sample preparation: Ensure complete lysis and denaturation of proteins. For yeast samples, effective sonication (10 minutes using 30-second on/off cycles) is crucial for efficient protein extraction .

• Cross-reactivity analysis: Use bioinformatics tools to identify proteins with similar epitopes to YHR054C in your experimental system, which might be causing cross-reactivity.

If inconsistency persists, consider batch-to-batch variation in antibody production. Standardized antibody characterization efforts like YCharOS can help identify more reliable antibodies through side-by-side comparisons of commercially available options .

What are the key differences in using YHR054C antibody for Western blot versus immunoprecipitation?

The application of YHR054C antibody differs significantly between Western blot and immunoprecipitation techniques, requiring specific optimization for each:

Western Blot Application:

• Protein state: Proteins are denatured with SDS, so the antibody recognizes linear epitopes.

• Sample preparation: Use RIPA buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1% NP-40, 0.25% Sodium Deoxycholate, 1 mM EDTA pH 8.0, 20% glycerol) for cell lysis, followed by sonication for 10 minutes (30s on/off cycles) .

• Antibody conditions: Apply primary antibody in PBST containing 5% BSA overnight at 4°C, followed by secondary antibody in PBST with 5% milk for 1 hour at room temperature .

• Detection sensitivity: Typically detects 20-50 μg of total protein.

• Controls: Include molecular weight markers, loading controls, and knockout controls.

Immunoprecipitation Application:

• Protein state: Proteins maintain native conformation and interactions, so the antibody must recognize conformational epitopes.

• Sample preparation: Gentler lysis buffers to preserve protein-protein interactions.

• Antibody amount: Typically requires more antibody (2-5 μg per reaction).

• Pre-clearing step: Often necessary to reduce non-specific binding.

• Controls: Include IgG control, input sample (pre-IP), and knockout control.

• Validation: Confirm successful IP by Western blotting a portion of the immunoprecipitated material.

For both applications, specificity validation using YHR054C knockout strains is essential. The immunoprecipitation protocol may need additional optimization for chromatin immunoprecipitation, including crosslinking with 1% formaldehyde, sonication to shear chromatin, and specific washing conditions with buffers of increasing stringency .

How should I interpret conflicting results between YHR054C antibody signal and gene expression data?

When faced with discrepancies between YHR054C antibody signal and gene expression data, a methodical investigation approach is necessary:

• Post-transcriptional regulation: Protein levels may not directly correlate with mRNA levels due to differences in translation efficiency, protein stability, or post-translational modifications. Compare your results with proteomics data when available.

• Antibody specificity: Verify the antibody's specificity using knockout controls. False positives can occur due to cross-reactivity with similar proteins, while false negatives may result from epitope masking by protein interactions or modifications .

• Technical variations: Differences in experimental conditions between protein and RNA detection methods can contribute to discrepancies. Standardize sample preparation and normalization approaches across experiments.

• Temporal dynamics: RNA and protein have different turnover rates. Time-course experiments may reveal a temporal offset between mRNA and protein expression changes.

• Spatial considerations: In cellular fractionation studies, the antibody may detect protein in specific subcellular compartments, while RNA data represents whole-cell expression.

• Antibody characterization: Consider using multiple antibodies targeting different epitopes of YHR054C to increase confidence in protein detection .

To resolve these conflicts, implement orthogonal validation approaches, such as mass spectrometry-based protein quantification or fluorescent protein tagging. The standardized antibody characterization platform developed by YCharOS provides valuable resources for evaluating antibody reliability in different applications , helping to distinguish true biological complexity from technical artifacts.

What are the best practices for quantifying YHR054C protein levels using immunoblotting?

Accurate quantification of YHR054C protein levels through immunoblotting requires meticulous attention to experimental design and analysis:

• Sample preparation standardization:

  • Use consistent lysis conditions with RIPA buffer

  • Standardize sonication protocols (10 minutes with 30s on/off cycles at 70% intensity)

  • Determine protein concentration using a reliable method (BCA or Bradford assay)

  • Prepare all samples simultaneously to minimize batch effects

• Loading controls and normalization:

  • Include multiple loading controls (e.g., GAPDH, actin, total protein stain)

  • Consider using stain-free technology or Ponceau S staining for total protein normalization

  • Ensure loading controls are in the linear range of detection

  • For yeast samples, Pgk1 or Tdh1 are commonly used as housekeeping controls

• Standard curve inclusion:

  • Generate a standard curve using purified recombinant YHR054C protein when available

  • Include a dilution series of a reference sample to establish linearity of detection

• Image acquisition and analysis:

  • Use a digital imaging system with a broad dynamic range (e.g., LI-COR Odyssey FC)

  • Avoid saturated pixels, which prevent accurate quantification

  • Perform background subtraction consistently across all samples

  • Use dedicated software (ImageJ, Image Studio) for densitometry analysis

• Replication and statistics:

  • Include biological replicates (minimum n=3) in experimental design

  • Perform technical replicates for each biological sample

  • Apply appropriate statistical tests to determine significance of observed differences

  • Report both raw and normalized data with measures of variability

• Validation:

  • Confirm key findings with orthogonal methods (flow cytometry, ELISA, mass spectrometry)

  • Consider complementary approaches like cycloheximide chase to determine protein half-life

By adhering to these best practices, researchers can obtain reliable quantitative data on YHR054C protein levels that withstand rigorous scientific scrutiny.

How can I optimize immunofluorescence protocols for detecting YHR054C in yeast cells?

Optimizing immunofluorescence protocols for detecting YHR054C in yeast cells requires addressing the unique challenges of yeast cell wall and fixation:

• Cell wall digestion:

  • Create spheroplasts by treating cells with zymolyase (100T at 0.5-1 mg/ml) for 30 minutes at 30°C

  • Monitor spheroplast formation microscopically or by testing osmotic sensitivity

  • Alternative: use mutant strains with weakened cell walls for easier antibody penetration

• Fixation optimization:

  • Test both formaldehyde (4% for 15-30 minutes) and methanol:acetone (1:1 at -20°C for 6 minutes) fixation

  • For membrane-associated or hydrophobic proteins, formaldehyde followed by detergent permeabilization may preserve localization better

  • Include fixation controls to ensure antigen preservation and accessibility

• Permeabilization conditions:

  • Test different detergents (0.1% Triton X-100, 0.1% Tween-20, or 0.5% SDS) for optimal balance between antibody accessibility and structural preservation

  • Optimize permeabilization time (typically 5-15 minutes) to minimize background

• Blocking and antibody incubation:

  • Use 5% BSA or 5% normal serum from the same species as the secondary antibody

  • Extend primary antibody incubation time (overnight at 4°C) to improve signal

  • Test different antibody dilutions to determine optimal signal-to-noise ratio

• Signal amplification:

  • Consider tyramide signal amplification for low-abundance proteins

  • Use high-sensitivity detection systems with minimal autofluorescence (e.g., Alexa Fluor dyes)

  • Include appropriate filters to minimize yeast autofluorescence (particularly in the FITC channel)

• Controls and validation:

  • Include a YHR054C knockout strain as a negative control

  • Use GFP-tagged YHR054C strain (if available) as a positive control

  • Perform co-localization with known organelle markers to confirm subcellular localization

• Image acquisition:

  • Use confocal microscopy to improve signal-to-noise ratio and spatial resolution

  • Acquire Z-stacks to capture the entire cell volume

  • Apply deconvolution algorithms to enhance resolution

By systematically optimizing these parameters, researchers can achieve specific and sensitive detection of YHR054C protein in its native cellular context.

What strategies can I use to detect post-translational modifications of YHR054C using antibody-based methods?

Detecting post-translational modifications (PTMs) of YHR054C requires specialized approaches combining antibody-based methods with advanced techniques:

• PTM-specific antibodies:

  • For common modifications, use commercially available antibodies against phosphorylation, acetylation, ubiquitination, or SUMOylation

  • Verify PTM-antibody specificity using appropriate controls (phosphatase-treated samples for phosphorylation)

  • Consider raising custom antibodies against predicted modification sites on YHR054C

• Two-dimensional Western blotting:

  • Separate proteins by isoelectric point followed by molecular weight

  • Detect YHR054C using specific antibody

  • PTMs often cause shifts in isoelectric point or apparent molecular weight

• Immunoprecipitation-based approaches:

  • Use YHR054C antibody for immunoprecipitation, then probe with PTM-specific antibodies

  • Alternatively, use PTM-specific antibodies for IP, then detect YHR054C

  • Include negative controls (IgG, knockout) and positive controls (known modified proteins)

• Mass spectrometry validation:

  • Immunoprecipitate YHR054C and analyze by mass spectrometry for definitive PTM identification

  • Combine with enrichment strategies specific to phosphopeptides (TiO₂, IMAC) or ubiquitinated peptides (K-ε-GG antibodies)

• Phos-tag technology:

  • For phosphorylation detection, use Phos-tag acrylamide gels that specifically retard migration of phosphorylated proteins

  • Compare migration patterns with and without phosphatase treatment

• Proximity ligation assay (PLA):

  • Combine YHR054C antibody with PTM-specific antibody

  • Only generates signal when both epitopes are in close proximity (<40 nm)

  • Provides spatial information about modified protein within cells

• Inducible systems:

  • Manipulate conditions known to induce specific PTMs (e.g., stress conditions, cell cycle arrest)

  • Monitor changes in YHR054C modification state using the methods above

These methods can be combined in complementary ways to build strong evidence for specific modifications of YHR054C, contributing to a deeper understanding of its regulation and function.

How can I use YHR054C antibody in combination with other techniques for studying protein-protein interactions?

Investigating protein-protein interactions involving YHR054C can be accomplished through several complementary antibody-based techniques:

• Co-immunoprecipitation (Co-IP):

  • Use YHR054C antibody to pull down the protein complex

  • Analyze co-precipitated proteins by mass spectrometry or Western blotting

  • Include appropriate controls: IgG control, YHR054C knockout, and input samples

  • Consider crosslinking to stabilize transient interactions

  • Optimize lysis conditions to preserve native interactions (avoid harsh detergents)

• Proximity-dependent labeling:

  • Create fusion proteins of YHR054C with BioID or APEX2

  • Identify proteins in close proximity through biotinylation followed by streptavidin pulldown

  • Validate key interactions using YHR054C antibody in reciprocal Co-IP

• Chromatin immunoprecipitation (ChIP):

  • For DNA-associated functions, use YHR054C antibody in ChIP experiments

  • Follow optimal ChIP conditions: crosslinking with 1% formaldehyde for 10 minutes, sonication for 45 minutes with 30s on/off cycles, and stringent washing

  • Combine with sequential ChIP (re-ChIP) to identify protein complexes at specific genomic locations

• Immunofluorescence co-localization:

  • Use YHR054C antibody in combination with antibodies against suspected interacting proteins

  • Analyze co-localization through confocal microscopy and quantitative image analysis

  • Consider super-resolution techniques for nanoscale interaction studies

• Förster Resonance Energy Transfer (FRET):

  • Combine YHR054C antibody with fluorescently labeled secondary antibodies

  • Use antibodies against potential interaction partners with compatible FRET fluorophores

  • Measure energy transfer as evidence of close proximity (<10 nm)

• Protein complementation assays:

  • Generate split-reporter fusions (e.g., split-GFP) with YHR054C and potential partners

  • Validate interactions using YHR054C antibody in orthogonal assays

• Pull-down validation:

  • Perform reciprocal Co-IPs using antibodies against identified interaction partners

  • Use YCharOS-validated antibodies when available to ensure specificity

  • Include negative controls to rule out non-specific binding

By combining these complementary approaches, researchers can build a comprehensive understanding of YHR054C's interaction network and functional relationships within the cell.

What are the considerations for using YHR054C antibody in comparative studies across different yeast strains?

When using YHR054C antibody across different yeast strains, researchers must address several critical considerations:

• Sequence conservation analysis:

  • Compare the YHR054C sequence across target strains to identify variations that might affect antibody recognition

  • Focus particularly on the epitope region recognized by the antibody

  • Consider using multiple antibodies targeting different epitopes if strain variations are significant

• Validation in each strain:

  • Verify antibody specificity in each strain using knockout controls when available

  • For strains without available knockouts, use overexpression controls or RNAi-mediated knockdown

  • Perform side-by-side Western blots to compare signal characteristics across strains

• Normalization strategy:

  • Identify housekeeping proteins that show consistent expression across your strains

  • Consider total protein normalization methods (Ponceau S, stain-free technology) that are less dependent on specific reference proteins

  • Include loading controls with known expression stability across the strains under study

• Experimental design:

  • Process all strain samples simultaneously under identical conditions

  • Include a common reference sample across all experiments for inter-experimental normalization

  • Design experiments with sufficient biological and technical replicates to account for strain variability

• Growth condition standardization:

  • Standardize culture conditions (media composition, growth phase, temperature)

  • Consider that different strains may reach equivalent growth phases at different rates

  • Document strain-specific growth characteristics for accurate interpretation

• Cross-reactivity assessment:

  • Test for cross-reactivity with closely related proteins that may be differentially expressed across strains

  • Use mass spectrometry validation for ambiguous cases

How can I incorporate YHR054C antibody in high-throughput screening approaches?

Incorporating YHR054C antibody in high-throughput screening requires systematic optimization and standardization:

• Assay miniaturization and automation:

  • Adapt Western blot protocols to microplate format using dot blot or in-cell Western techniques

  • Optimize antibody concentrations to maintain sensitivity while reducing cost

  • Develop automated liquid handling protocols for consistent sample preparation and antibody application

• Detection system selection:

  • Choose detection methods compatible with high-throughput readouts (fluorescence, chemiluminescence)

  • Consider infrared fluorescent secondary antibodies for improved quantitative range and multiplexing capabilities

  • Validate detection system linearity across the expected range of YHR054C expression

• Screening platform development:

  • For genetic screens, develop reporter systems linked to YHR054C expression or function

  • For chemical screens, establish dose-response relationships and appropriate time points

  • Include positive and negative controls on each plate for quality control and normalization

• Data analysis pipeline:

  • Implement robust statistical methods for hit identification (Z-score, B-score)

  • Develop analysis workflows that account for plate-to-plate variation

  • Include visualization tools for pattern recognition across large datasets

• Validation strategies:

  • Design confirmation assays using orthogonal methods

  • Include secondary screens to filter false positives

  • Validate key hits using conventional YHR054C antibody-based assays

• Multiplex opportunities:

  • Combine YHR054C detection with other markers to increase information content

  • Consider antibody-based bead arrays for multiplexed protein detection

  • Validate antibody performance in multiplexed format to ensure specificity is maintained

• Quality control measures:

  • Implement rigorous antibody validation using standardized platforms like YCharOS

  • Include technical replicates and inter-plate controls

  • Monitor assay performance using statistical process control methods

By methodically addressing these aspects, researchers can develop robust high-throughput screening platforms incorporating YHR054C antibody, enabling large-scale studies of genetic and chemical perturbations affecting YHR054C expression or function.

What approaches can I use to validate novel findings from YHR054C antibody-based experiments?

Validating novel findings from YHR054C antibody-based experiments requires a multi-faceted approach:

• Orthogonal detection methods:

  • Confirm protein expression or localization using epitope tagging (HA, FLAG, GFP)

  • Employ mass spectrometry-based proteomics for unbiased protein identification

  • Correlate with mRNA expression data while accounting for potential post-transcriptional regulation

• Genetic validation:

  • Generate YHR054C knockout or knockdown strains to confirm antibody specificity

  • Perform rescue experiments by reintroducing YHR054C to knockout strains

  • Use CRISPR-Cas9 to introduce specific mutations and observe effects on antibody recognition

• Multiple antibody validation:

  • Test multiple antibodies targeting different epitopes of YHR054C

  • Compare results from monoclonal and polyclonal antibodies

  • Utilize standardized antibody validation platforms like YCharOS that perform side-by-side testing of commercial antibodies

• Functional assays:

  • Design functional readouts based on known or predicted YHR054C activities

  • Correlate antibody-detected expression levels with functional outcomes

  • Develop quantitative assays that can measure dose-dependent effects

• Cross-laboratory validation:

  • Collaborate with independent laboratories to replicate key findings

  • Share detailed protocols including lot numbers of antibodies used

  • Consider blind sample testing to eliminate experimenter bias

• Technical controls:

  • Include isotype controls, secondary-only controls, and knockout controls

  • Perform competition assays with purified antigen when available

  • Demonstrate expected behavior under known perturbations (e.g., stress conditions)

• Computational validation:

  • Use bioinformatic approaches to predict protein behavior and compare with experimental results

  • Analyze public datasets for corroborating evidence

  • Apply machine learning methods to identify consistent patterns across diverse datasets

By systematically implementing these validation approaches, researchers can build a compelling body of evidence that supports the reliability and biological significance of their YHR054C antibody-based findings.